Dayton Misfeldt, Director at SUNESIS PHARMACEUTICALS INC (SNSS), bought 400,000 shares at $2.00 ($800K) on 2017-10-27, disclosed to the SEC on 2017-10-30.
Open-market purchase of $800k SNSS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.00 | 7,480 | $15K | 1.9% |
| 2 | $2.00 | 392,520 | $785K | 98.1% |
| Total | $2.00 avg | 400,000 | $800K | 100% |
| Filing → |
| SNSS | SELL | 2014-08-29 | $2.4M | — | Filing → |
| SNSS | SELL | 2014-08-12 | $4.9M | — | Filing → |
| SNSS | BUY | 2010-07-01 | $6.7M | — | Filing → |